When people describe what they want from a nootropic, the answer tends to be some combination of greater focus, sharper memory, and the ability to keep performing when concentration starts to fade.

These are reasonable goals, and the most common way of pursuing them involves stimulating the brain’s existing chemistry to produce more output in the moment.

The limitation of this approach is that it does not build anything new. It draws on resources the brain already has, and when that borrowing happens repeatedly without sufficient recovery, this negative effect tends to outweigh the short-term benefit.

A different area of research has been developing alongside this more familiar approach to nootropics, with less focus on how sharp someone feels in a given afternoon and more attention on the biological conditions that determine how well the brain functions over years and decades.

The Problem With Always Reaching for More Stimulation

Stimulant-style nootropics work by amplifying the brain compounds that drive alertness, motivation, and focus.

Dopamine (the brain’s reward and drive signal) and noradrenaline (involved in alertness and attention) are the most common targets. The effects of increasing the levels of these two compounds are recognised quite quickly. 

The issue is what happens afterwards. The brain is a homeostatic system, which means it actively resists being pushed too far in any one direction. When you repeatedly stimulate it to produce more output, it adapts by becoming less responsive to that stimulation.

For specific, occasional demands, stimulant-style nootrpics can be useful. The problem comes from treating them as a long-term brain health strategy.

What Neurotrophic Actually Means and Why It Matters

The word neurotrophic comes from “neuro” (relating to the nervous system) and “trophic” (relating to nourishment and growth).

Neurotrophic compounds are studied for their role in supporting the conditions under which brain cells grow, survive, and maintain their connections.

The protein of focus in this field is BDNF, which stands for brain-derived neurotrophic factor. BDNF supports the growth and survival of neurons, helps strengthen the connections between them, and plays a central role in neuroplasticity (the brain’s ability to adapt, reorganise, and form new pathways).

BDNF naturally declines with age and falls further under sustained stress, while factors such as exercise and deep sleep are known to raise it. Researchers are now exploring whether certain peptides can support BDNF activity in a similar way. 

2 Peptides and a Different Angle on the Same Problem

Semax and Selank are the two peptides most consistently referenced in neurotrophic nootropic research.

They do not do the same thing, but they are often discussed together because they address complementary aspects of brain health.

Semax

Semax is a synthetic peptide derived from ACTH (adrenocorticotropic hormone), a hormone involved in the body’s stress and adaptation response. In nootropic research, Semax is studied primarily for its relationship to BDNF and NGF (nerve growth factor, another protein involved in supporting and maintaining specific neurons).

This 2021 study in the International Journal of Molecular Sciences examined Semax’s effects on brain protein expression in an animal model of stroke. The findings pointed to measurable effects on the proteins involved in brain cell survival and recovery, supporting Semax’s neuroprotective research profile.

Semax is typically administered as a nasal spray, which allows it to reach the brain quickly via the nasal pathway rather than having to pass through the digestive system.

Selank Nasal Spray, 10mg | 15ml

Selank

Where Semax focuses on neurotrophic support directly, Selank approaches brain health from a different direction: the stress response.

This is important because chronic stress is one of the most reliable suppressors of BDNF activity. A brain under sustained stress is a brain that struggles to adapt, recover, and maintain the conditions that cognitive performance depends on.

Selank is studied for its anxiolytic (anxiety-reducing) properties. A 2018 study by Vyunova et al., published in Protein and Peptide Letters, found that Selank works through a distinct pathway compared to conventional anti-anxiety medications. 

Selank produces prolonged anti-anxiety and nootropic effects without the dependency or memory impairment issues typically associated with those drugs.

Selank is also typically administered as a nasal spray.

Selank Nasal Spray, 10mg | 15ml

What to Realistically Expect From This Approach

Neurotrophic nootropics are not intended to replace foundational habits such as sleep and exercise. They are also not designed to produce a noticeable effect within the hour. This gradual approach is central to how the model is meant to work, rather than a limitation of it.

Research is exploring whether compounds like Semax and Selank can support the biological infrastructure of brain health over a similar timeframe to exercise and sleep. Effects typically develop over weeks rather than hours, and individual response varies considerably.

Most of the evidence in this space remains early-stage or preclinical, and long-term human safety data is still developing. As with all research peptides, professional guidance before starting any protocol is strongly recommended.

Want to Learn More About Neurotrophic Peptide Research?

Whether you are curious about how Semax and Selank fit into a broader approach to brain health, or you want to understand the research before committing to any protocol, a conversation with someone who knows the science is the most useful place to start.

Schedule a 1:1 consultation with one of our Peptide Therapy Experts

Frequently Asked Questions (FAQs)

What is the difference between a nootropic and a neurotrophic compound?

Nootropic is a broad term covering any compound studied for cognitive enhancement. Neurotrophic refers specifically to compounds that support the growth, survival, and maintenance of brain cells. All neurotrophic compounds could be called nootropics, but not all nootropics are neurotrophic. The distinction lies in whether a compound is amplifying existing brain activity or supporting the biological infrastructure that produces it.

What is a BDNF?

BDNF (brain-derived neurotrophic factor) is a protein that supports the growth and survival of neurons and plays a central role in neuroplasticity, the brain’s ability to adapt and form new connections. Higher BDNF activity is associated with better learning, memory consolidation, and cognitive resilience. Lower BDNF is linked to cognitive decline, chronic stress, and ageing.

Why do stimulant nootropics stop working over time?

The brain adapts to sustained stimulation through a process called downregulation, where it reduces its sensitivity to a signal that is repeatedly amplified. The result is that the same dose produces a weaker effect over time. This is why relying on stimulant-style nootropics as a daily strategy tends to result in diminishing returns and a lower baseline cognitive state when the compound is not being used.

How do lifestyle factors like sleep and exercise relate to nootropic research?

Exercise, sleep, and stress management all raise BDNF activity through the brain’s own mechanisms. Neurotrophic peptides like Semax and Selank are studied for their potential to support these same biological systems. This is why they are positioned as complements to a healthy lifestyle rather than replacements for one.

Are Semax and Selank safe?

Both compounds are broadly considered well-tolerated in the existing research. As with all research-stage peptides, long-term human safety data continues to develop. Professional consultation before starting any protocol is strongly advisable, particularly when considering dosing, timing, and cycle length.